510(k) Report

510(k) · Cleared

Cleared

Novabone Putty- Bioactive Synthetic Graft

K080009510(k) TraditionalCleared May 6, 2008124-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Novabone Products, LLC · MQV Filler, Bone Void, Calcium Compound

Cleared on May 6, 2008 as substantially equivalent to K060728 (Novabone Products, LLC, 2006) and 2 other predicates after a 124-day review. Its family tree reaches back 4 generations to 1996. 71 later devices descend from it.

Decided
May 6, 2008
Review
124 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 4 generations to K960978 (1996). 10 ancestors in all. 71 later devices descend from it, 13 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor2005: 1 other ancestor2004: 1 other ancestor1997: 1 other ancestor2001: 2 other ancestors2011: 4 descendants cleared2017: 3 descendants cleared2010: 2 descendants cleared2013: 2 descendants cleared2009: 2 descendants cleared2008: 1 descendant cleared2015: 4 descendants cleared2014: 6 descendants cleared2024: 8 descendants cleared2020: 2 descendants cleared2023: 9 descendants cleared2016: 1 descendant cleared2022: 3 descendants cleared2018: 3 descendants cleared2026: 6 descendants cleared2019: 1 descendant cleared2021: 1 descendant cleared2025: 13 descendants clearedK960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 1996K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K021336 · Novabone-Resorbable Bone Graft Substitute · Novabone Products, LLC · 2002K052494 · Novabone-Bioactive Synthetic Graft · Novabone Products, LLC · 20051995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 3 other ancestors3 generations back: 2 other ancestors 1 generation forward: 13 descendants2 generations forward: 17 descendants3 generations forward: 23 descendants4 generations forward: 13 descendants5 generations forward: 4 descendants6 generations forward: 1 descendant K052494 · Novabone-Bioactive Synthetic Graft · Novabone Products, LLC · 2005K021336 · Novabone-Resorbable Bone Graft Substitute · Novabone Products, LLC · 2002K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 19960+5
  1. Root · 4 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 3 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 2 generations backK021336 Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2002
  4. 1 generation backK052494 Novabone-Bioactive Synthetic GraftNovabone Products, LLC · 2005
  5. This deviceK080009 Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC · 2008
  6. Descendant · cites it directly · 59 of its ownK082672 Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008
  7. Descendant · cites it directly · 47 of its ownK101860 Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010
  8. Descendant · cites it directly · 43 of its ownK110368 Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011
  9. Descendant · cites it directly · 38 of its ownK112773 Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011
  10. Descendant · 2 generations on · 33 of its ownK132805 BG MorselsProsidyan, Inc. · 2014

Showing 5 of 71 descendants. See all descendants

Descendants cleared per year

2008: 12009: 22010: 22011: 42013: 22014: 62015: 42016: 12017: 32018: 32019: 12020: 22021: 12022: 32023: 92024: 82025: 132026: 6
2008high 13 (2025) · low 0 (2012)2026

Most influential descendants

Showing 5 of 71 · See all
  • K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008 · cites it directly59descendants
  • K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010 · cites it directly47descendants
  • K110368Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011 · cites it directly43descendants
  • K112773Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC · 2011 · cites it directly38descendants
  • K132805BG MorselsProsidyan, Inc. · 2014 · 2 generations on33descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−3K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−2K021336Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC2002—
−1K052494Novabone-Bioactive Synthetic GraftNovabone Products, LLC2005—
0 (this device)K080009Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC2008—
+1K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC2008—
+1K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC2010—
+1K110368Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC2011—
+1K112773Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC2011—
+2K132805BG MorselsProsidyan, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200120
200410
200510
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200920
201020
201140
201320
201460
201540
201610
201730
201830
201910
202020
202110
202230
202390
202480
2025130
202660
FIG. 1 — Lineage of K080009, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K060728Novabone Putty - Bioactive Synthetic Graft
Summary page 1
…Bone Void Filler 3. Legally Marketed Predicate Device: Predicate #1: NovaBone Putty - Bioactive Synthetic Graft - [K060728] Predicate #2: NovaBone - Resorbable Bone Graft Substitute - [K021336, K052494]…
Novabone Products, LLC2006—
*K021336Novabone-Resorbable Bone Graft Substitute
Summary page 1
…ynthetic Graft - [K060728] Predicate #2: NovaBone - Resorbable Bone Graft Substitute - [K021336, K052494] 4. Device Description NovaBone Putty is an osteoconductive, bioactive, bone void filler device. It is compo…
Novabone Products, LLC2002—
*K052494Novabone-Bioactive Synthetic Graft
Summary page 1
…Graft - [K060728] Predicate #2: NovaBone - Resorbable Bone Graft Substitute - [K021336, K052494] 4. Device Description NovaBone Putty is an osteoconductive, bioactive, bone void filler device. It is composed of a…
Novabone Products, LLC2005—

Also cleared against K060728: 13 other devices →

What descends from it? (71)

See all 71

13 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC200859
K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC201047
K110368Novabone Putty - Bioactive Synthetic Bone GraftNovabone Products, LLC201143
K112773Novabne Putty Bioactive Synthetic Bone GraftNovabone Products, LLC201138
K143533Fibergraft BG Putty Bone Graft SubstituteProsidyan, Inc.201531
K170306FIBERGRAFT BG Putty Bone Graft SubstituteProsidyan, Inc.201730
K090731Novabone Porous - Synthetic Bone Graft ScaffoldNovabone Products, LLC200910
K130392Kinex BioactiveGlobus Medical, Inc.20138
K240404NovaBone Putty - Bioactive Synthetic Bone Graft (NB6600, NB6610, NB6615)Novabone Products, LLC20241
K140844Biosphere Bioactive Bone Graft Putty, 2.5CC, 5CC, 10CCSynergy Biomedical, Inc.20141

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 3.3 years on median.
  • 1 of the 10 ancestors has a recall of any class.
  • Of its descendants, K082672 (Novabone Products, LLC, 2008) has gone furthest, with 59 descendants of its own.
  • 13 other devices also cite its predicate K060728.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

NovaBone Putty - Bioactive Synthetic Graft is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. NovaBone Putty is indicated to be gently packed into bony voids or gaps of the skeletal system (i.e. the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and…

Read the full statement (162 words)

NovaBone Putty - Bioactive Synthetic Graft is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. NovaBone Putty is indicated to be gently packed into bony voids or gaps of the skeletal system (i.e. the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process.

NovaBone Putty is not indicated for use in load-bearing applications. It does not possess sufficient mechanical strength to support load-bearing defects prior to hard tissue ingrowth. It should not be used for vertebroplasty or kyphoplasty procedures. In cases of fracture fixation or where load support is required, standard internal or external stabilization techniques must be followed to obtain rigid stabilization in all planes. NovaBone Putty must not be used to gain screw purchase or to stabilize screw placement.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080009: Novabone Putty- Bioactive Synthetic Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080009

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026